95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.50%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.30%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-5.62%
Negative EBIT growth while AEM is at 24.23%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-5.62%
Negative operating income growth while AEM is at 24.23%. Joel Greenblatt would press for urgent turnaround measures.
-16.06%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-10.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11.11%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.34%
Share reduction more than 1.5x AEM's 1.29%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.70%
Diluted share reduction more than 1.5x AEM's 1.57%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-2.65%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-2.65%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
141.24%
10Y revenue/share CAGR at 50-75% of AEM's 207.57%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
124.47%
5Y revenue/share CAGR at 75-90% of AEM's 159.43%. Bill Ackman would encourage strategies to match competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
40.43%
Below 50% of AEM's 208.81%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-7.79%
Negative 3Y OCF/share CAGR while AEM stands at 132.88%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
622.91%
5Y net income/share CAGR at 50-75% of AEM's 1032.96%. Martin Whitman might see a shortfall in operational efficiency or brand power.
229.95%
Positive short-term CAGR while AEM is negative. John Neff would see a clear advantage in near-term profit trajectory.
874.54%
Equity/share CAGR of 874.54% while AEM is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
1188.92%
5Y equity/share CAGR above 1.5x AEM's 344.87%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-88.33%
Negative 3Y equity/share growth while AEM is at 164.09%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-13.81%
Firm’s AR is declining while AEM shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
60.34%
Asset growth above 1.5x AEM's 4.99%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.70%
75-90% of AEM's 2.15%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.06%
We cut SG&A while AEM invests at 1.59%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.